Back
Cocrystal Pharma Vs. Cara Therapeutics Industry Stock Comparison
Buy
58
COCP
Cocrystal Pharma
Last Price:
1.79
Seasonality Move:
10.39%
Sell
40
CARA
Cara Therapeutics
Last Price:
0.32
Seasonality Move:
5.28%
Buy
58
Cocrystal Pharma (COCP)
is a Buy
Is Cocrystal Pharma a Buy, Sell or Hold?
- The current Cocrystal Pharma [COCP] share price is $1.80. The Score for COCP is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- COCP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
COCP Stock Price Chart
What is Cocrystal Pharma's stock price today?
-
The Cocrystal Pharma share price today is $1.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COCP is experiencing selling pressure, which indicates risk of future bearish movement.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CARA is experiencing slight selling pressure.
COCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 46.9 | Sell |
| Chaikin Money Flow: | -40602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.72 - 1.98) | Sell |
| Bollinger Bands (100): | (1.7 - 2.26) | Sell |
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 54.9 | Buy |
| Chaikin Money Flow: | -44360 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.25 - 0.29) | Buy |
| Bollinger Bands (100): | (0.27 - 0.35) | Sell |
COCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.81 | Sell |
| 20-day SMA: | 1.88 | Sell |
| 50-day SMA: | 1.8 | Buy |
| 200-day SMA: | 1.83 | Sell |
| 8-day EMA: | 1.83 | Sell |
| 20-day EMA: | 1.85 | Sell |
| 50-day EMA: | 1.85 | Sell |
| 200-day EMA: | 1.93 | Sell |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.29 | Buy |
| 20-day SMA: | 0.27 | Buy |
| 50-day SMA: | 0.29 | Buy |
| 200-day SMA: | 0.53 | Sell |
| 8-day EMA: | 0.29 | Buy |
| 20-day EMA: | 0.28 | Buy |
| 50-day EMA: | 0.3 | Sell |
| 200-day EMA: | 0.75 | Sell |
Cocrystal Pharma Earnings Growth & COCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.27 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
Cocrystal Pharma Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cara Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||